JORDAN BROSSI

Issues related to funding of childrens hospital graduate medical education program (CHGME); issues related to research funding; funding for community project and pediatric pandemic network; issues related to recruitment of pediatric specialists; support for Illinois State Directed Payment Program.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); site neutral legislation affecting front line hospitals.

Support for study of centers of excellence for military-civilian trauma partnerships.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); transparency issues and modernization related to 340B Drug Discount Program; support Health Safety-Net Program for high need hospitals; development of improvement to trauma payments for HHS and Congress.

Issues related to hearing loss and treatment.

Issues related to hearing loss and treatment; H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027; H.R.9495 - Department of Defense Appropriations Act, 2027.

Issues related to hearing loss and treatment; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

FY 2027 Center for Disease Control Appropriations - Request for Centers for Disease Control to update infection control guidelines.

Department of Health & Human Services contracting.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.

Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; Drug Shortages; Medicaid Generics Penalty.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.

FEMA reimbursement of hospital COVID costs.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.

Issues related to hearing loss and treatment; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027.

Issues related to hearing loss and treatment; H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027; H.R.9495 - Department of Defense Appropriations Act, 2027.

S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Coverage of radiation therapy treatments.

Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Support for revising trauma activation fees to ensure appropriate trauma volume.

Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.

Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.

Issues related to funding of childrens hospital graduate medical education program (CHGME); issues related to research funding; funding for community project and pediatric pandemic network; issues related to recruitment of pediatric specialists; support for Illinois State Directed Payment Program.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); transparency issues and modernization related to 340B Drug Discount Program; support Health Safety-Net Program for high need hospitals; development of improvement to trauma payments for HHS and Congress.

Support for study of centers of excellence for military-civilian trauma partnerships.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); site neutral legislation affecting front line hospitals.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; support for approval of Colorado provider tax.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding.

FEMA reimbursement of hospital COVID costs.

FY 2027 Center for Disease Control Appropriations - Request for Centers for Disease Control to update infection control guidelines.

Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.

Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.

Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.

Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.

Issues related to hearing loss and treatment.

Issues related to hearing loss and treatment.

Issues related to hearing loss and treatment.

FY 2027 Appropriations - Request for Centers for Disease Control to update recommendations on hospital infection control best practices.

Issues related to hearing loss and treatment.

Issues related to hearing loss and treatment.

Issues related to hearing loss and treatment.

S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Women's health care issues; outreach related to Sickle Cell and other rare disease legislation; H.R. 1750 - Health Equity and Rare Disease Act of 2025; H.R. 1414 - Camerons Law; S.822 - Scientific EXPERT Act of 2025; H.R.1262 - Mikaela Naylon Give Kids a Chance Act.

Support for renewal of Haiti HOPE/HELP duty free exemption for apparel manufactured in Haiti, H.R.1625/S.742 - Haiti Economic Lift Program Extension Act of 2025.

Issues related to funding of childrens hospital graduate medical education program (CHGME); issues related to research funding; funding for community project and pediatric pandemic network; issues related to recruitment of pediatric specialists; support for Illinois State Directed Payment Program.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); transparency issues and modernization related to 340B Drug Discount Program; support Health Safety-Net Fund for high need hospitals; development of improvement to trauma payments for HHS and Congress.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); site neutral legislation affecting front line hospitals.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; support for approval of Colorado provider tax.

S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.

Coverage of radiation therapy treatments.

Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Support for renewal of Haiti HOPE/HELP duty free exemption for apparel manufactured in Haiti, H.R.1625/S.742 - Haiti Economic Lift Program Extension Act of 2025.

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Support efforts to reduce healthcare acquired infections (HAIs) and improve infection prevention effort.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); transparency issues and modernization related to 340B Drug Discount Program; support Health Safety-Net Fund for high need hospitals.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); site neutral legislation affecting front line hospitals.

Issues related to funding of childrens hospital graduate medical education program (CHGME); issues related to research funding; funding for community project and pediatric pandemic network; issues related to recruitment of pediatric specialists; support for Illinois State Directed Payment Program; raising awareness of immigration issue for a pediatric subspecialist.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress.

Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding.

Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act (S. 2561 / H.R. 5768).

Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561/H.R. 5768).

Coverage of radiation therapy treatments.

Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Women's health care issues; outreach related to Sickle Cell and other rare disease legislation; H.R. 1750 - Health Equity and Rare Disease Act of 2025; H.R. 1414 - Camerons Law; S.822 - Scientific EXPERT Act of 2025; H.R.1262 - Mikaela Naylon Give Kids a Chance Act.

Support increased funding for cancer-related federal programs.

Funding for cancer-related health services.

Support for renewal of Haiti HOPE/HELP duty free exemption for apparel manufactured in Haiti, H.R.1625/S.742 - Haiti Economic Lift Program Extension Act of 2025.

Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561).

Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); FDA rulemaking on ultraprocessed food.

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Women's health care issues; outreach related to Sickle Cell Legislation.

Support increased funding for cancer-related federal programs.

Funding for cancer-related health services.

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Support efforts to reduce healthcare acquired infections (HAIs) and improve infection prevention effort.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues and modernization related to 340B Drug Discount Program; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues related to 340B Drug Discount Program, site neutral legislation affecting front line hospitals; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

Federal Employee Health Benefits (FEHB) Protection Act, Medicaid program integrity.

Medicare coverage of wound care therapies.

Coverage of radiation therapy treatments.

Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Support efforts to reduce healthcare acquired infections (HAIs) and improve infection prevention effort.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.

Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256).

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues related to 340B Drug Discount Program, site neutral legislation affecting front line hospitals; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues and modernization related to 340B Drug Discount Program; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Women's health care issues; outreach related to Sickle Cell Legislation.

Support increased funding for cancer-related federal programs.

Funding for cancer-related health services.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues and modernization related to 340B Drug Discount Program; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

Advocacy for front line hospitals; statutory recognition of front line hospitals and Medicaid and Medicare funding for disproportionate share hospitals (H.R. 7327); demonstration program on physical and mental health comorbidities (S.3450); transparency issues related to 340B Drug Discount Program, site neutral legislation affecting front line hospitals; Medicaid and other provisions in H.R. 1 - the One Big Beautiful Bill Act.

Medicare coverage of wound care therapies.